Funded Tech Companies
858 Therapeutics
Wondering who backed 858 Therapeutics? New Enterprise Associates, Logos Capital and Versant Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
858 Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4757 Nexus Center Dr. 150
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response. 858 was founded by a veteran team who together bring a track record of success in pharma and biotech drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/23/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Stafford
Chief Scientific Officer
James Veal
Vice President
Gretchen Bain
Company Investors
- New Enterprise Associates
- Logos Capital
- Versant Ventures
- Cormorant Asset Management
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs